Home » Epilepsy Blog » News and Research » Living Well With Epilepsy Founder chats LIVE with the Healtheo360 team

Living Well With Epilepsy Founder chats LIVE with the Healtheo360 team

In my role as Founder of Living Well With Epilepsy, I am often asked to speak to people about epilepsy. I was recently invited to be the guest host on h360 LIVE, which is Healtheo360’s live talk show. The show was fun and I thought you might want to take a look. Below you can view a recording of the broadcast:

What did you think?

Let us know what thought about the show with a comment below. If you enjoyed the show let the Healtheo360 team know by giving it a thumbs up on their site.

Later this month

Toward the end of September I will head to Chicago for the American Neurological Association’s 140th Annual Meeting. This is a fantastic opportunity to hear directly from leading researchers about trends in neurology research and what is in the pipeline for new epilepsy therapies. I am looking forward to my visit to Chicago!

author avatar
Jessica K. Smith Founder and CEO; Executive Director
Jessica Keenan Smith is a patient advocate and epilepsy community leader with more than 15 years of experience. As Founder and CEO of Living Well With Epilepsy and Executive Director of ASENT she bridges the gap between the scientific and patient communities, with a particular focus on the needs of the epilepsies. Jessica Keenan Smith is Founder and CEO of Living Well With Epilepsy, an award winning online resource for people affected by epilepsy to share stories and access in-depth information on the disease. Since 2009, Living Well With Epilepsy (https://livingwellwithepilepsy.com) has been featured in Forbes, Wired, NBC, NPR and the cover story of Epilepsy Advocate Magazine and has partnered with companies such as UCB, Lundbeck, Sunovion, Eisai, and more. Ms. Smith is also the Executive Director of the American Society for Experimental Neurotherapeutics (ASENT) (https://asent.org), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. In this role she is responsible for leading a successful scientific journal and annual scientific conference with speakers from all over the world.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.